Clinical Trials Logo

Colorectal Cancer Metastatic clinical trials

View clinical trials related to Colorectal Cancer Metastatic.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT02286492 Approved for marketing - Clinical trials for Colorectal Cancer Metastatic

Expanded Access Study of TAS-102 in Patients With Metastatic Colorectal Cancer

Start date: n/a
Phase: N/A
Study type: Expanded Access

The objective of the program is to provide access to TAS-102 to patients with metastatic colorectal cancer who are refractory to or failing standard chemotherapy, are new to therapy with TAS-102 and in whom therapy with TAS-102 is clinically indicated.